ArticleClinical ophthalmology (Auckland, N.Z.)2010

Use of nepafenac (Nevanac) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections.

Eric Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.